InHealth Intelligence Limited

Information

Name

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

Address

Cheshire

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with InHealth Intelligence Limited
Sign up free

Contracts awarded to InHealth Intelligence Limited

The contracts that InHealth Intelligence Limited have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 1 month ago

NHS Diabetic Eye Screening Programme London Region

NHS England (London Region) (hereafter referred to as "the Authority") is seeking to re-commission 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: •Identifies the eligible population and ensures effective delivery with maximum coverage. •Is safe, effective, high quality, externally and independently monitored, and quality assured. •Leads to earlier detection, appropriate referral, effective treatment and improved outcomes. •Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes. •Has audit embedded in the service. •Works effectively with other stakeholders to ensure the care pathway is smooth and efficient. There are 3 key elements of service delivery, namely: •Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance. •Digital surveillance where individuals need more frequent screening. •Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). Optical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. The Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024. The 7-year estimated contract values, based on predicted activity levels, are: Lot 1 = £33,703,069, Lot 2 = £18,930,476, Lot 3 = £28,062,012, Lot 4 = £21,533,552, Lot 5 = £18,120,336 Please note, the full indicative contract values per each financial year can be found in the tender documentation. Additional information: NHS England proposes an activity-based financial model with the following tariffs: • Routine digital screening (RS001) - £39.10 per screen. • Slit lamp bio-microscopy (SLB003) - £48.29 per screen. • Digital surveillance (DS002) - £39.10 per screen. • Prisons screening (PS004) - £78.21 per screen. • Forensics screening (FS005) - £58.65 per screen. The Commissioner's ambition through the financial model is to encourage uptake of DESP to achieve or exceed the national achievable target of 85% uptake in routine screening (DE1). The Services will be commissioned using the NHS DESP National Service Specification 23-24, localised where appropriate. National changes to screening frequency for low-risk individuals are expected to be implemented during the contract term which will have an impact on activity. The subsequent impact on contract values will be agreed between the Provider and the Commissioner via contract variation. Activity projections used in this procurement do not account for these future changes as further clarity around timeline and implementation guidance is expected in the future. Further information is provided in the tender documentation. Interested providers may bid for one, multiple or all lots. However, if successful across multiple lots following evaluation, bidders will be awarded no more than two lots. The Procurement is being managed by the NHS London Commercial Hub (NHS LCH) hosted by NEL ICB, on behalf of the Authority, in connection with a competitive Invitation to Tender (ITT) exercise that is being conducted via a process, based in part on the open procedure under the Public Contract Regulations 2015 ("the Regulations" (as amended)). The Service falls within the scope of the Light Touch Regime (LTR) - Section 7 (Reg 74-76) of the Regulations governing procurement of Health, Social and related services listed under Schedule 3 of the Regulations. None of the references to "Open procedure", "ITT", the use of the term "tender process", or any other indication shall be taken to mean that the Authority intends to hold itself bound to any of the Regulations, save those applicable to LTR provisions. The tendering process will be conducted in accordance with the requirements and flexibilities provided by Articles 74 to 76 of the Directive, and Regulations 74 to 76 of the Regulations. The Authority will run a transparent tender process, treating all Bidders equally. For the avoidance of doubt, the Authority will not be bound by the Regulations or the Treaty on the Functioning of the European Union or any other regulations or legislation except for the specific parts or circumstances that apply to the procurement of these Services. The Contracting Authority intends to voluntarily observe the award decision notices provisions and 10-day standstill period described in Regulation 86 of the Regulations.

£124,030,876 Bids close: 1 year ago
Award

Published 1 month ago

NHS Diabetic Eye Screening Programme London Region

The award notice concerns the procurement of 5 Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of North West London (Lot 1), North Central London (Lot 2), North East London (Lot 3), South East London (Lot 4), and South West London (Lot 5). The eligible population includes patients over the age of 12 diagnosed with diabetes registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: •Identifies the eligible population and ensures effective delivery with maximum coverage. •Is safe, effective, high quality, externally and independently monitored, and quality assured. •Leads to earlier detection, appropriate referral, effective treatment and improved outcomes. •Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education, continuous professional development and quality assurance schemes. •Has audit embedded in the service. •Works effectively with other stakeholders to ensure the care pathway is smooth and efficient. There are 3 key elements of service delivery, namely: •Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance. •Digital surveillance where individuals need more frequent screening. •Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). Optical Coherence Tomography (OCT) does not form part of this Contract at this time, though this position may change over the life of the contract in line with national guidance. The Contract term will be 5 years, with an option to extend for a further 2 years at the sole discretion of the Commissioner. The Contracts are due to commence on 01/07/2024. The 7-year estimated contract values, based on predicted activity levels, are: Lot 1 = £33,703,069, Lot 2 = £18,930,476, Lot 3 = £28,062,012, Lot 4 = £21,533,552, Lot 5 = £18,120,336 Please note, the full indicative contract values per each financial year can be found in the tender documentation.

£117,158,691
Award

Published 1 month ago

NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East

NHS England South East (NHSE) sought to commission a Provider(s) which have the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. The procurement was divided into 5 lots within the South East as follows: Lot 1: Kent and Medway (ICB footprint) Lot 2: Surrey Heartlands (ICB footprint) Lot 3: Hampshire and IOW (ICB footprint) Lot 4: Berkshire (Local Authority) and Frimley (ICB footprint) Lot 5: Oxfordshire and Buckinghamshire (Local Authority footprint) Providers were able to bid for one or all Lots. Contracts are for a term of 5 years, with the option to extend for up to a further 3 years. Services are planned to commence from 1st April 2025. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This should be achieved by delivering an evidence-based service that: • focuses on improving uptake, reducing inequalities, and improving outcomes • is accessible across all service elements • is engaging, and integrated, working effectively with service users and stakeholders to ensure seamless and high-quality care • is safe, effective, and high quality, with robust processes along the pathway • embed a culture of quality, improvement, and learning • is well-led, managed, and staffed There are three key elements of service delivery, namely: • routine digital screening - from 2025 and 2026, all eligible patients are to be managed on 12- or 24-month intervals • Digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required • Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g., those having cataracts) Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance. The total contract values for the 5 year initial term were advertised as follows: Lot 1: Kent and Medway - £17,755,303 Lot 2: Surrey Heartlands - £8,084,825 Lot 3: Hampshire and IOW - £16,695,800 Lot 4: Berkshire and Frimley - £11,311,121 Lot 5: Oxfordshire and Buckinghamshire - £9,927,015 This notice serves as an intention to award a contract under the competitive process of the Provider Selection Regime (PSR). This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners. Additional information: The decision to award this contract in line with the Competitive Process was based on evaluation against the basic selection criteria (in the form of a Selection Questionnaire), which was assessed on a pass/fail basis, the PSR 5 key criteria, plus staffing and mobilisation, which were assessed on a 0-4 scale, with the below weightings. Several tender questions were asked under each of the key criteria. - Quality and Innovation: 38% - Value: 5% - Integration, Collaboration and Service Sustainability: 19% - Improving Access, Reducing Health Inequalities, and Facilitating Choice: 15% - Social Value: 13% - Staffing and mobiliation: 10% The provider(s) selected for award have been chosen as they passed the basic selection criteria and were the highest scoring bidder overall, against the key criteria. After conducting a thorough Competitive Process, taking into account the key criteria and applying the basic selection criteria, NHS England South East is content that the provider's bids sufficiently met the key criteria and thus can proceed to contract award under the Health Care Services (Provider Selection Regime) Regulations 2023. The evaluation panel consisted of representatives from NHS England South East, including Commissioning, Screening & Immunisations, Finance, Human Resources, and Nursing & Quality. Award decisions have been recommended by the Head of Public Health Commissioning for Hampshire & Thames Valley (NHSE SE), and the Senior Public Health Commissioning Manager (NHSE SE). Award decisions have been made by key members of the South East Regional Executive Team (SERET), namely, the South East Regional Director (also Chair) and the Regional Director of Commissioning for the South East. There were two potential declarations of conflict of interest made via the conflict of interest process and recorded accordingly; these were not decision makers. Conflicts were appropriately managed, with one personnel being removed from the process. The other conflict recorded, upon review, was not deemed as an actual (or perceived conflict). This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by Midnight Monday 21st October. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners. Written representations should be sent to [email protected]

£59,607,052 Bids close: 5 months ago
Award

Published 1 month ago

NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East

NHS England South East (NHSE) sought to commission a Provider(s) which had the capability and capacity to deliver Diabetic Eye Screening Programmes (DESP) across the South East region, in line with the specified requirements. The procurement was divided into 5 lots within the South East as follows: Lot 1: Kent and Medway (ICB footprint) Lot 2: Surrey Heartlands (ICB footprint) Lot 3: Hampshire and IOW (ICB footprint) Lot 4: Berkshire (Local Authority) and Frimley (ICB footprint) Lot 5: Oxfordshire and Buckinghamshire (Local Authority footprint) Providers were able to bid for one or all Lots. Contracts are for a term of 5 years, with the option to extend for up to a further 3 years. Services are planned to commence from 1st April 2025. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with a GP, as well as individuals within prisons, secure units, and the armed forces. The aim of the Diabetic Eye Screening Programme is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight-threatening diabetic retinopathy. This should be achieved by delivering an evidence-based service that: • focuses on improving uptake, reducing inequalities, and improving outcomes • is accessible across all service elements • is engaging, and integrated, working effectively with service users and stakeholders to ensure seamless and high-quality care • is safe, effective, and high quality, with robust processes along the pathway • embed a culture of quality, improvement, and learning • is well-led, managed, and staffed There are three key elements of service delivery, namely: • routine digital screening - from 2025 and 2026, all eligible patients are to be managed on 12- or 24-month intervals • digital surveillance where more frequent screening of those individuals who may be at increased risk of developing diabetic retinopathy but have not reached the threshold to be referred into the Hospital Eye Services (HES), as required • slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g., those having cataracts) Optical Coherence Tomography (OCT) will be introduced into the programme across England in line with national guidance. The total contract values for the 5 year initial term were advertised as follows: Lot 1: Kent and Medway - £17,755,303 Lot 2: Surrey Heartlands - £8,084,825 Lot 3: Hampshire and IOW - £16,695,800 Lot 4: Berkshire and Frimley - £11,311,121 Lot 5: Oxfordshire and Buckinghamshire - £9,927,015 This notice serves as an intention to award a contract under the competitive process of the Provider Selection Regime (PSR). This procurement has been carried out by NHS South, Central and West Commissioning Support Unit (SCW) on behalf of the Commissioners.

£60,397,774
Award

Published 9 months ago

Child Health Information Service

Child Health Information Service This procurement references the service and quality indicators expected by NHS England (the Commissioner) from the CHIS (the Service) to ensure that a high standard of service is provided to NHS England's responsible population. The service specification is not designed to replicate, duplicate, or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2012, or the work undertaken by the Care Quality Commission (CQC). In the event of new guidance emerging, the specification will be reviewed and amended as quickly as possible, but, where necessary, both the Commissioner and the Provider will work proactively to agree speedy variations of contract ahead of a revised specification being produced. Current immunisation, screening and other public health programmes may be subject to nationally prescribed changes in response to recommendations from the Joint Committee on Vaccination and Immunisation (JCVI), the United Kingdom National Screening Committee (UKNSC) or the Department of Health and Social Care (DHSC) as advancements in evidence-based practice emerge. The Service, and its associated IT System, is expected to have the capability to adapt promptly to, and implement, such prescribed changes.

£54,481,635
Award

Published 9 months ago

Child Health Information Services

This procurement references the service and quality indicators expected by NHS England (the Commissioner) from the Child Health Information Service (CHIS) (the Service,) to ensure that a high standard of service is provided to NHS England's responsible population. The service specification is not designed to replicate, duplicate, or supersede any relevant legislative provisions which may apply, e.g. the Health and Social Care Act 2012, or the work undertaken by the Care Quality Commission (CQC). In the event of new guidance emerging, the specification will be reviewed and amended as quickly as possible, but, where necessary, both the Commissioner and the Provider will work proactively to agree speedy variations of contract ahead of a revised specification being produced. Current immunisation, screening and other public health programmes may be subject to nationally prescribed changes in response to recommendations from the Joint Committee on Vaccination and Immunisation (JCVI), the United Kingdom National Screening Committee (UKNSC) or the Department of Health and Social Care (DHSC) as advancements in evidence-based practice emerge. The Service and its associated IT System is expected to have the capability to adapt promptly to, and implement, such prescribed changes. The Provider will not subcontract any element of the Service without the prior permission of the Commissioner. Contract Length and value. The contract for the Service is 5 years 01.04.24 -31/03/29 with an option to extend for a further two years. The Procurement process will be facilitated entirely online via ProContract portal. Interested Applicants wishing to participate in the procurement must register, express an interest and complete the online questionnaires hosted on the portal prior to the deadline for submission. A timetable for the procurement, guidance re: process, and supplementary information relating to each contract opportunity is also available from the portal. https://procontract.due-north.com/Procurer/Advert/AdvertSummary?projectId=5c17e3eb-94bd-ed11-8120-005056b64545&projectStepId=6017e3eb-94bd-ed11-8120-005056b64545 This Tender process is being managed by NHS London Shared Service (NEL Commissioning Support Unit) on behalf of The Authority in connection with a competitive procurement exercise that is being conducted in accordance with a process based on the Open Procedure under the Public Contract Regulations 2015 ("the Regulations" (as amended)). The services to which this Procurement relates fall within the "Light Touch Regime" (LTR) governing the procurement of Health, Social, Education and Other service contracts. Neither the reference to "Open Procedure", "ITT", "SQ", the use of the term "Tender process", nor any other indication shall be taken to mean that the Contracting Authority intends to hold itself bound to any of the Regulations, save those applicable to LTR provisions.

£54,481,637 Bids close: 1 year ago

InHealth Intelligence Limited

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to InHealth Intelligence Limited

NHS Diabetic Eye Screening Programme London Region

NHS Diabetic Eye Screening Programme London Region

NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East

NHS England South East - Diabetic Eye Screening Programmes (DESP) across the South East

Child Health Information Service

Child Health Information Services

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win